近岸蛋白
(688137)
| 流通市值：112.14亿 | | | 总市值：112.14亿 |
| 流通股本：6991.75万 | | | 总股本：6991.75万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 78,496,109.52 | 37,246,747.9 | 146,439,493.07 | 111,854,902.43 |
| 营业总成本 | 96,100,027.51 | 43,448,993.89 | 185,997,982.61 | 131,176,781.29 |
| 其他经营收益 | | | | |
| 营业利润 | -28,728,868.64 | -11,441,654.34 | -69,854,916.48 | -38,134,755.05 |
| 利润总额 | -28,757,914.26 | -11,459,749.3 | -70,373,566.58 | -38,502,182.01 |
| 净利润 | -29,204,508.82 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 |
| 每股收益 | | | | |
| 其他综合收益 | 269,942.66 | 126,512.97 | 113,649.11 | 41,526.76 |
| 综合收益总额 | -28,934,566.16 | -10,477,854.78 | -77,669,742.45 | -28,817,741.74 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,817,665,244.63 | 1,835,431,197.02 | 1,854,968,138.39 | 1,913,643,135.62 |
| 非流动资产: | | | | |
| 非流动资产合计 | 321,217,633.85 | 310,454,083.66 | 296,580,509.01 | 281,595,410.16 |
| 资产总计 | 2,138,882,878.48 | 2,145,885,280.68 | 2,151,548,647.4 | 2,195,238,545.78 |
| 流动负债: | | | | |
| 流动负债合计 | 96,869,818.37 | 79,032,339 | 69,122,049.59 | 74,540,466.05 |
| 非流动负债: | | | | |
| 非流动负债合计 | 43,487,087.01 | 45,816,444.08 | 47,704,334.1 | 40,241,178.02 |
| 负债合计 | 140,356,905.38 | 124,848,783.08 | 116,826,383.69 | 114,781,644.07 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,998,525,973.1 | 2,021,036,497.6 | 2,034,722,263.71 | 2,080,456,901.71 |
| 股东权益合计 | 1,998,525,973.1 | 2,021,036,497.6 | 2,034,722,263.71 | 2,080,456,901.71 |
| 负债和股东权益合计 | 2,138,882,878.48 | 2,145,885,280.68 | 2,151,548,647.4 | 2,195,238,545.78 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 91,171,101.34 | 39,753,508.71 | 179,219,557.67 | 124,352,186.12 |
| 经营活动现金流出小计 | 113,926,877.49 | 53,832,691.8 | 192,581,566.27 | 141,850,598.44 |
| 经营活动产生的现金流量净额 | -22,755,776.15 | -14,079,183.09 | -13,362,008.6 | -17,498,412.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 881,327,938.94 | 268,727,909.39 | 2,747,048,796.17 | 1,854,996,609.6 |
| 投资活动现金流出小计 | 817,526,279.88 | 183,858,552.37 | 2,644,904,523.69 | 1,668,277,112 |
| 投资活动产生的现金流量净额 | 63,801,659.06 | 84,869,357.02 | 102,144,272.48 | 186,719,497.6 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 16,103,640.71 | 8,180,515.13 | 23,825,361.43 | 16,796,060.52 |
| 筹资活动产生的现金流量净额 | -16,103,640.71 | -8,180,515.13 | -23,825,361.43 | -16,796,060.52 |
| 汇率变动对现金及现金等价物的影响 | -1,692,057.59 | -834,984.79 | -1,132,277.19 | -573,163.17 |
| 现金及现金等价物净增加额 | 23,250,184.61 | 61,774,674.01 | 63,824,625.26 | 151,851,861.59 |
| 期末现金及现金等价物余额 | 734,062,637.69 | 772,587,127.09 | 710,812,453.08 | 798,839,689.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 23,250,184.61 | - | 63,824,625.26 | - |